ISRA - ETF AI Analysis
Top Page
VanEck Israel ETF (ISRA)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Overall Year-to-Date Performance
The ETF has delivered solid gains so far this year, suggesting its mix of holdings has recently worked well for investors.
Leading Tech Holding with Strong Gains
The largest position, Palo Alto Networks, has shown very strong performance, providing a meaningful boost to the fund.
Balanced Israel and U.S. Exposure
The fund splits its assets between Israel and the U.S., giving investors access to Israeli companies while still maintaining significant exposure to the U.S. market.
Negative Factors
High Concentration in Top Holding
Palo Alto Networks makes up a sizable share of the portfolio, so any setback in this single stock could have an outsized impact on the ETF.
Heavy Tilt Toward Technology
A large portion of the fund is invested in technology companies, which can make the ETF more sensitive to swings in the tech sector.
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of going to investors.
ISRA vs. SPDR S&P 500 ETF (SPY)
AUM150.23M
RegionMiddle East & Africa
Expense Ratio0.59%
Beta0.81
IssuerVanEck
Inception DateJun 25, 2013
Dividend Yield1.36%
Asset ClassEquity
Index TrackedBlueStar Israel Global Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,438
30 Day Avg. Volume6,850
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ISRA Summary
The VanEck Israel ETF (ISRA) tracks the BlueStar Israel Global Index and gives you broad exposure to Israeli-linked companies, many of which are known for innovation and technology. It holds well-known names like Palo Alto Networks and Teva Pharmaceutical, along with banks and other businesses, so you’re not betting on just one sector. Someone might invest in ISRA to diversify their portfolio geographically and tap into the growth potential of Israel’s tech-driven economy. A key risk is that it’s heavily tied to the Israeli market, so its price can swing with regional events and overall market ups and downs.
How much will it cost me?The VanEck Israel ETF (ISRA) has an expense ratio of 0.59%, which means you’ll pay $5.90 per year for every $1,000 invested. This is slightly higher than average because the fund is focused on a specific niche market (Israeli securities) and requires more active management compared to broad, passively managed index funds.
What would affect this ETF?The VanEck Israel ETF (ISRA) could benefit from Israel's strong reputation in technology and innovation, particularly in cybersecurity, biotechnology, and clean energy, which are key drivers of growth. However, potential risks include geopolitical tensions in the Middle East and global economic slowdowns, which could negatively impact the financial and industrial sectors that make up a significant portion of the ETF's holdings.
ISRA Top 10 Holdings
ISRA leans heavily into Israel’s tech story, with Palo Alto Networks and Tower Semiconductor acting as key engines of recent gains, both riding strong momentum despite some valuation worries. Defense player Elbit Systems has also been a steady contributor, benefiting from resilient demand. On the flip side, Teva Pharmaceutical has been lagging, and JFrog’s mixed, volatility-prone performance can tug at returns. A cluster of major Israeli banks like Leumi and Poalim adds financial ballast. Overall, the fund is a tech-tilted, Israel-only play with a supporting cast in defense and finance.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Palo Alto Networks | 12.42% | $18.68M | $270.44B | 91.94% | 73 Outperform | |
| Teva Pharmaceutical | 7.35% | $11.05M | $41.33B | 127.63% | 63 Neutral | |
| Leumi | 5.65% | $8.50M | ₪106.53B | 20.18% | 80 Outperform | |
| Poalim | 5.12% | $7.70M | ₪97.22B | 21.56% | 79 Outperform | |
| Elbit Systems | 4.39% | $6.59M | ₪115.34B | 57.82% | 73 Outperform | |
| Tower | 3.66% | $5.50M | ₪75.19B | 391.76% | 76 Outperform | |
| Mizrahi Tefahot | 2.30% | $3.46M | ₪59.22B | 13.51% | 80 Outperform | |
| Phoenix | 2.25% | $3.39M | ₪43.34B | 53.68% | 79 Outperform | |
| Discount | 2.16% | $3.25M | ₪39.10B | 2.76% | 75 Outperform | |
| JFrog | 1.98% | $2.98M | $9.66B | 90.34% | 73 Outperform |
ISRA Technical Analysis
Neutral
―
Price Trends
65.41
Negative
65.08
Negative
62.18
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ISRA, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 64.44, equal to the 50-day MA of 65.41, and equal to the 200-day MA of 62.18, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ISRA.
ISRA Peer Comparison
Comparison Results
Performance Comparison
ISRA
VanEck Israel ETF
64.06
14.48
29.21%
JHMD
John Hancock Multifactor Developed International ETF
―
―
―
IDHQ
Invesco S&P International Developed High Quality ETF
―
―
―
DMXF
iShares ESG Advanced MSCI EAFE ETF
―
―
―
PID
Invesco International Dividend Achievers ETF
―
―
―
EIS
iShares MSCI Israel ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents